Evidence map›Paper›PMID 36700073›Full record

ArticleFrontiers in chemistry2022

Development of the DNA-based voltammetric biosensor for detection of vincristine as anticancer drug.

Mahmoud Abbasi, Fahad Alsaikhan, Rasha Fadhel Obaid, Shohreh Jahani, Saeed Biroudian, Maziar Oveisee, Mohammad Reza Arab, Zahra Aramesh-Boroujeni, Mohammad Mehdi Foroughi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 12 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 3 countries.

Mahmoud AbbasiMedical Ethics and Law Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Fahad AlsaikhanCollege of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi Arabia.
Rasha Fadhel ObaidDepartment of Biomedical Engineering, Al-Mustaqbal University College, Babylon, Iraq.
Shohreh JahaniNoncommunicable Diseases Research Center, Bam University of Medical Sciences, Bam, Iran.
Saeed BiroudianDepartment of Medical Ethics, Medical School, Iran University of Medical Sciences, Tehran, Iran.
Maziar OveiseeOrthopedic Department, Bam University of Medical Sciences, Bam, Iran.
Mohammad Reza ArabDepartment of Medical, Bam University of Medical Sciences, Bam, Iran.
Zahra Aramesh-BoroujeniDepartment of Chemistry, University of Isfahan, Isfahan, Iran.
Mohammad Mehdi ForoughiDepartment of Chemistry, Kerman Branch, Islamic Azad University, Kerman, Iran.
Bam University of Medical Sciences · IRIran University of Medical Sciences · IRIslamic Azad University Kerman · IRPrince Sattam Bin Abdulaziz University · SAShahid Beheshti University of Medical Sciences · IRUniversity of Babylon · IQUniversity of Isfahan · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the article presented herein, a deoxyribonucleic acid (DNA) biosensor is introduced for Vincristine determination in pharmaceutical preparations based on the modification of screen printed electrode (SPE) with double-stranded DNA (ds-DNA), polypyrrole (PP), peony-like CuO:Tb

Indexed as

DNA biosensorpeony-like CuO:Tb 3+ nanostructurepolypyrrolevincristinevoltammetry

Identifiers

PMID36700073
PMCPMC9870317
OpenAlexW4317243024

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.